- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MP-23-0064281

Medestrom India Private Limited
About Medestrom India Private Limited
Data last updated:
Medestrom India Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 13 August 2022.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24290MP2022PTC062247.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saket Litoriya (Managing Director) and Anubhav Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 227 Veda Building Bhanwarkuan Road, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.04 Lakh. For the same year it recorded a net profit of ₹34,107 (net margin 2.4%) and EBITDA of ₹76,163 (EBITDA margin 5.4%).
Medestrom India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0064281). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Medestrom India
Contact details
Medestrom India Private Limited's registered office is in Indore, Madhya Pradesh.
- Registered AddressShop No. 227 Veda Building Bhanwarkuan Road, Indore, Madhya Pradesh, India – 452001
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medestrom India Private Limited
FY 2025 filings availableMedestrom India Private Limited reported revenue of ₹14.04 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹76,163 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹34,107 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 5.4% | ||
| Net Profit Margin | 2.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Medestrom India Private Limited, buy the company report.
Board of directors of Medestrom India Private Limited
Medestrom India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saket Litoriya | Managing Director | 13 Aug 2022 | 4 Years 2 Months | Current |
| Anubhav Jain | Director | 26 Nov 2024 | 1 Years 11 Months | Current |
Peer comparison
Medestrom India Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cytogen Pharmaceuticals (India) Private Limited | ₹14.23 Lakh (FY 2022) | -16.0% | New Delhi, Delhi, India | |||
| Jaivirs Pharmaceuticals Private Limited | ₹14.22 Lakh (FY 2024) | -5.0% | Mumbai, Maharashtra, India | |||
| Akron Consumer Care Private Limited | ₹14.22 Lakh (FY 2025) | -53.0% | Muppalla, Andhra Pradesh, India | |||
| Poldwin Healthcare Private Limited | ₹14.07 Lakh (FY 2024) | 1261.0% | Chandigarh, India | |||
| A-Rich Lab Private Limited | ₹14.05 Lakh (FY 2024) | -35.0% | Patna, Bihar, India | |||
| Medestrom India Private Limitedthis company | ₹14.04 Lakh (FY 2025) | ₹34,107 | 2.4% | Indore, Madhya Pradesh, India | ||
| Aurochem India Private Limited | ₹14.03 Lakh (FY 2025) | 6.0% | New Delhi, Delhi, India | |||
| Noblecare Remedies Private Limited | ₹13.98 Lakh (FY 2025) | -24.0% | Gurgaon, Haryana, India | |||
| Mindswift Pharmaceuticals Private Limited | ₹13.97 Lakh (FY 2025) | 35.0% | Pune, Maharashtra, India | |||
| Aspire Lifesciences Private Limited | ₹13.92 Lakh (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Biovams Pharmaceuticals Private Limited | ₹13.9 Lakh (FY 2025) | -87.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Medestrom India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medestrom India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medestrom India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medestrom India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medestrom India Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Anubhav Jain was appointed as Director on 26 Nov 2024.
Frequently asked questions
Medestrom India is an active private limited company based in Indore, Madhya Pradesh, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 13 August 2022 (4+ years old) and is registered under CIN U24290MP2022PTC062247.
Medestrom India has 2 current directors:
- Saket Litoriya - Managing Director
- Anubhav Jain - Director
The latest financial statements of Medestrom India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Medestrom India is U24290MP2022PTC062247. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medestrom India was incorporated on 13 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Medestrom India by revenue are Cytogen Pharmaceuticals (India) Private Limited, Jaivirs Pharmaceuticals Private Limited, Akron Consumer Care Private Limited, Poldwin Healthcare Private Limited, A-Rich Lab Private Limited and 5 more, all in the Pharma industry (Formulations).
Anubhav Jain was appointed as Director on 26 Nov 2024. Renu Dubey ceased to be Director on 26 Nov 2024. Saket Litoriya was appointed as Managing Director on 13 Aug 2022.
Yes, Medestrom India is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0064281).
The registered office of Medestrom India is at Shop No. 227 Veda Building Bhanwarkuan Road, Indore, Madhya Pradesh, India – 452001.
Medestrom India operates in the chemicals industry, in the other chemical product segment.
The compliance status of Medestrom India is compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.

